140 related articles for article (PubMed ID: 8982478)
1. Acidity near eroding polylactide-polyglycolide in vitro and in vivo in rabbit tibial bone chambers.
Martin C; Winet H; Bao JY
Biomaterials; 1996 Dec; 17(24):2373-80. PubMed ID: 8982478
[TBL] [Abstract][Full Text] [Related]
2. Comparative bone healing near eroding polylactide-polyglycolide implants of differing crystallinity in rabbit tibial bone chambers.
Winet H; Bao JY
J Biomater Sci Polym Ed; 1997; 8(7):517-32. PubMed ID: 9195331
[TBL] [Abstract][Full Text] [Related]
3. Incorporation of polylactide-polyglycolide in a cortical defect: neoangiogenesis and blood supply in a bone chamber.
Winet H; Hollinger JO; Stevanovic M
J Orthop Res; 1995 Sep; 13(5):679-89. PubMed ID: 7472746
[TBL] [Abstract][Full Text] [Related]
4. Fibroblast growth factor-2 alters the effect of eroding polylactide-polyglycolide on osteogenesis in the bone chamber.
Winet H; Bao JY
J Biomed Mater Res; 1998 Jun; 40(4):567-76. PubMed ID: 9599033
[TBL] [Abstract][Full Text] [Related]
5. Effect of poly DL-lactide--co-glycolide implants and xenogeneic bone matrix-derived growth factors on calvarial bone repair in the rabbit.
Meikle MC; Papaioannou S; Ratledge TJ; Speight PM; Watt-Smith SR; Hill PA; Reynolds JJ
Biomaterials; 1994 Jun; 15(7):513-21. PubMed ID: 7918904
[TBL] [Abstract][Full Text] [Related]
6. Incorporation of polylactide-polyglycolide in a cortical defect: neoosteogenesis in a bone chamber.
Winet H; Hollinger JO
J Biomed Mater Res; 1993 May; 27(5):667-76. PubMed ID: 7686160
[TBL] [Abstract][Full Text] [Related]
7. Bone-derived growth factor release from poly(alpha-hydroxy acid) implants in vitro.
Meikle MC; Mak WY; Papaioannou S; Davies EH; Mordan N; Reynolds JJ
Biomaterials; 1993 Feb; 14(3):177-83. PubMed ID: 8386553
[TBL] [Abstract][Full Text] [Related]
8. Self-reinforced polylactide/polyglycolide 80/20 screws take more than 1(1/2) years to resorb in rabbit cranial bone.
Tiainen J; Soini Y; Törmälä P; Waris T; Ashammakhi N
J Biomed Mater Res B Appl Biomater; 2004 Jul; 70(1):49-55. PubMed ID: 15199583
[TBL] [Abstract][Full Text] [Related]
9. Non-invasive in vivo characterization of release processes in biodegradable polymers by low-frequency electron paramagnetic resonance spectroscopy.
Mader K; Gallez B; Liu KJ; Swartz HM
Biomaterials; 1996 Feb; 17(4):457-61. PubMed ID: 8938242
[TBL] [Abstract][Full Text] [Related]
10. Tissue responses to molecularly reinforced polylactide-co-glycolide implants.
Lewandrowski KU; Gresser JD; Wise DL; Trantolo DJ; Hasirci V
J Biomater Sci Polym Ed; 2000; 11(4):401-14. PubMed ID: 10903038
[TBL] [Abstract][Full Text] [Related]
11. Gel casting of resorbable polymers. 2. In-vitro degradation of bone graft substitutes.
Coombes AG; Heckman JD
Biomaterials; 1992; 13(5):297-307. PubMed ID: 1600032
[TBL] [Abstract][Full Text] [Related]
12. In vivo degradation characteristics of poly(glycerol sebacate).
Wang Y; Kim YM; Langer R
J Biomed Mater Res A; 2003 Jul; 66(1):192-7. PubMed ID: 12833446
[TBL] [Abstract][Full Text] [Related]
13. Antibiotic-loaded plaster of Paris implants coated with poly lactide-co-glycolide as a controlled release delivery system for the treatment of bone infections.
Benoit MA; Mousset B; Delloye C; Bouillet R; Gillard J
Int Orthop; 1997; 21(6):403-8. PubMed ID: 9498152
[TBL] [Abstract][Full Text] [Related]
14. Fibroblast growth factor-2 alters the effect of eroding polylactide-polyglycolide on angiogenesis in the bone chamber.
Winet H; Bao JY
Wound Repair Regen; 1997; 5(4):355-63. PubMed ID: 16984446
[TBL] [Abstract][Full Text] [Related]
15. Sustained release of ascorbate-2-phosphate and dexamethasone from porous PLGA scaffolds for bone tissue engineering using mesenchymal stem cells.
Kim H; Kim HW; Suh H
Biomaterials; 2003 Nov; 24(25):4671-9. PubMed ID: 12951010
[TBL] [Abstract][Full Text] [Related]
16. Preliminary report on the osteogenic potential of a biodegradable copolymer of polyactide (PLA) and polyglycolide (PGA).
Hollinger JO
J Biomed Mater Res; 1983 Jan; 17(1):71-82. PubMed ID: 6298242
[TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo degradation of porous poly(DL-lactic-co-glycolic acid) foams.
Lu L; Peter SJ; Lyman MD; Lai HL; Leite SM; Tamada JA; Uyama S; Vacanti JP; Langer R; Mikos AG
Biomaterials; 2000 Sep; 21(18):1837-45. PubMed ID: 10919687
[TBL] [Abstract][Full Text] [Related]
18. Polylactide-polyglycolide delivery system for physostigmine.
Hussain MA; Mollica JA
J Pharm Sci; 1993 May; 82(5):553-4. PubMed ID: 8360838
[No Abstract] [Full Text] [Related]
19. Long circulating biodegradable poly(phosphazene) nanoparticles surface modified with poly(phosphazene)-poly(ethylene oxide) copolymer.
Vandorpe J; Schacht E; Dunn S; Hawley A; Stolnik S; Davis SS; Garnett MC; Davies MC; Illum L
Biomaterials; 1997 Sep; 18(17):1147-52. PubMed ID: 9259511
[TBL] [Abstract][Full Text] [Related]
20. Osteoblast-like cell (MC3T3-E1) proliferation on bioerodible polymers: an approach towards the development of a bone-bioerodible polymer composite material.
Elgendy HM; Norman ME; Keaton AR; Laurencin CT
Biomaterials; 1993; 14(4):263-9. PubMed ID: 8386557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
